Anti–tumor necrosis factor therapy and Listeria monocytogenes infection: Report of two cases

This publication has 14 references indexed in Scilit:

• Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy
  New England Journal of Medicine, 2001
• Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
  Annual Review of Immunology, 2001
• Listerienarthritis bei chronischer Polyarthritis unter Low-dose-Prednisolon- und Methotrexat-Therapie
  Zeitschrift für Rheumatologie, 2001
• High incidence of Listeria monocytogenes in European red smear cheese
  International Journal of Food Microbiology, 2001
• Infliximab
  Drugs, 2000
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
  The Lancet, 1999
• A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
  New England Journal of Medicine, 1999
• Combination therapy with biologic agents in rheumatoid arthritis: Perils and promise
  Arthritis & Rheumatism, 1998
• The protective role of endogenous cytokines in host resistance against an intragastric infection withListeria monocytogenesin mice
  FEMS Immunology & Medical Microbiology, 1996
• Human tumor necrosis factor increases the resistance against Listeria infection in mice
  Medical Microbiology and Immunology, 1989